MedTrace Logo

Mind-Body Skills Groups for Incarcerated Men and Women

NCT05948917 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2025-12-10

No results posted yet for this study

Summary

The goal of this study is to learn about the effectiveness of a Mind-Body Skills Group program for incarcerated participants.The main questions is aims to answer are:

1. Do the mind-body skills groups increase resilience?
2. Do the mind-body skills groups decrease depression, anxiety and/or stress?
3. Do the mind-body skills groups increase participants' belief that they have improved coping skills?
4. Do the mind-body skills groups increase a sense of meaning in life?
5. Do the mind-body skills groups increase a sense of life purpose?
6. Do the mind-body skills groups increase self-esteem in women?
7. Do the mind-body skills groups decrease aggressive responses in men?

Conditions

  • Resilience

Interventions

BEHAVIORAL

Mind-Body Skills Groups

The mind-body skills groups consist of supportive small group sessions with about 8-10 participants per group. Participants of these groups learn and practice mind-body techniques including: meditation, self-expression through drawings, autogenics and biofeedback, guided imagery, body awareness, and genograms.

Sponsors & Collaborators

  • Herbert Simon Family Foundation

    collaborator UNKNOWN

  • The Center for Mind-Body Medicine

    lead OTHER

Principal Investigators

  • Julie K Staples, PhD · The Center for Mind-Body Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-05
Primary Completion
2025-06-19
Completion
2025-06-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05948917 on ClinicalTrials.gov